
Fortress Biotech FBIO
$ 1.87
0.53%
Country |
|
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
27.9 M |
Market Cap[1] |
$ 52.2 M |
EBITDA (LTM) |
$ -69.8 M |
P/E (LTM) |
-38.857143 |
P/S (LTM) |
1.199664 |
EPS (LTM) |
-0.07 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Royalty Pharma plc
RPRX
|
$ 60.96 | 2.25 % | $ 26.2 B | Nasdaq Global Select Market | ||
|
Seer
SEER
|
$ 2.03 | 0.44 % | $ 112 M | Nasdaq Global Select Market | ||
|
PDS Biotechnology Corporation
PDSB
|
$ 1.13 | 0.62 % | $ 52.4 M | Nasdaq Capital Market | ||
|
SIGA Technologies
SIGA
|
$ 3.17 | 0.16 % | $ 227 M | Nasdaq Global Select Market | ||
|
Nanobiotix S.A.
NBTX
|
$ 21.3 | 4.46 % | $ 1.02 T | Nasdaq Global Select Market | ||
|
Syndax Pharmaceuticals
SNDX
|
$ 12.9 | 0.89 % | $ 1.12 B | Nasdaq Global Select Market | ||
|
Soligenix
SNGX
|
$ 0.35 | 1.67 % | $ 1.82 M | Nasdaq Capital Market | ||
|
Intellia Therapeutics
NTLA
|
$ 11.42 | 0.71 % | $ 1.24 B | Nasdaq Global Market,SPB | ||
|
Nuvation Bio
NUVB
|
$ 4.45 | 1.6 % | $ 1.52 B | NYSE | ||
|
Sarepta Therapeutics
SRPT
|
$ 17.1 | 0.03 % | $ 1.71 B | Nasdaq Global Select Market,SPB | ||
|
Processa Pharmaceuticals
PCSA
|
$ 1.69 | 0.6 % | $ 2.21 M | Nasdaq Global Select Market | ||
|
RedHill Biopharma Ltd.
RDHL
|
$ 0.48 | 0.2 % | $ 5.91 B | Nasdaq Global Market | ||
|
SELLAS Life Sciences Group
SLS
|
$ 9.98 | 4.02 % | $ 1.09 B | Nasdaq Capital Market | ||
|
Protara Therapeutics
TARA
|
$ 2.32 | 1.46 % | $ 99.4 M | Nasdaq Global Market | ||
|
Relay Therapeutics
RLAY
|
$ 16.28 | 1.41 % | $ 2.79 B | Nasdaq Global Market | ||
|
Pfizer
PFE
|
$ 29.58 | 0.54 % | $ 168 B | NYSE,SPB | ||
|
Supernus Pharmaceuticals
SUPN
|
$ 37.88 | 0.5 % | $ 2.14 B | Nasdaq Global Select Market,SPB | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
$ 19.67 | 1.08 % | $ 31.1 B | NYSE | ||
|
Revolution Medicines
RVMD
|
$ 177.96 | 0.22 % | $ 33.8 B | Nasdaq Global Select Market | ||
|
Rhythm Pharmaceuticals
RYTM
|
$ 86.17 | 0.6 % | $ 5.6 B | Nasdaq Global Market,SPB | ||
|
Prelude Therapeutics Incorporated
PRLD
|
$ 3.26 | 0.9 % | $ 251 M | Nasdaq Global Select Market | ||
|
Sana Biotechnology
SANA
|
$ 2.27 | 6.22 % | $ 575 M | Nasdaq Global Select Market | ||
|
Pulmatrix
PULM
|
$ 1.36 | 4.61 % | $ 4.97 B | Nasdaq Global Select Market | ||
|
Zoetis
ZTS
|
$ 79.38 | 1.22 % | $ 35.2 B | NYSE,SPB | ||
|
Ultragenyx Pharmaceutical
RARE
|
$ 14.54 | 1.81 % | $ 1.43 B | Nasdaq Global Select Market,SPB | ||
|
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 1.96 | 2.62 % | $ 1.32 B | Nasdaq Capital Market | ||
|
Cleveland BioLabs, Inc.
CBLI
|
- | -7.31 % | $ 49 M | Nasdaq Capital Market | ||
|
Zymeworks
ZYME
|
$ 25.03 | 0.16 % | $ 1.29 B | NYSE | ||
|
AC Immune SA
ACIU
|
$ 2.39 | 2.08 % | $ 241 M | Nasdaq Global Market | ||
|
Five Prime Therapeutics, Inc.
FPRX
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Adagene
ADAG
|
$ 2.06 | 4.8 % | $ 122 M | Nasdaq Global Market | ||
|
Adial Pharmaceuticals
ADIL
|
$ 3.49 | 11.15 % | $ 2.33 M | Nasdaq Capital Market | ||
|
ADC Therapeutics SA
ADCT
|
$ 1.4 | 0.34 % | $ 178 M | NYSE | ||
|
ADMA Biologics
ADMA
|
$ 10.68 | 3.77 % | $ 2.55 B | Nasdaq Global Market | ||
|
Assembly Biosciences
ASMB
|
$ 20.09 | 0.19 % | $ 225 M | Nasdaq Global Select Market,SPB | ||
|
Allogene Therapeutics
ALLO
|
$ 1.31 | 3.08 % | $ 289 M | Nasdaq Global Select Market,SPB | ||
|
Amgen
AMGN
|
$ 432.49 | 0.08 % | $ 233 B | Nasdaq Global Select Market,SPB | ||
|
Ardelyx
ARDX
|
$ 3.09 | 2.51 % | $ 745 M | Nasdaq Global Market | ||
|
Armata Pharmaceuticals
ARMP
|
$ 3.37 | 9.06 % | $ 122 M | NYSE American | ||
|
Artelo Biosciences
ARTL
|
$ 2.7 | 0.36 % | $ 511 K | Nasdaq Global Select Market | ||
|
Biofrontera AG
BFRA
|
- | -8.24 % | $ 105 M | Nasdaq Capital Market | ||
|
Bicycle Therapeutics plc
BCYC
|
$ 3.46 | 2.56 % | $ 240 M | Nasdaq Global Select Market | ||
|
Catabasis Pharmaceuticals, Inc.
CATB
|
- | -6.97 % | $ 657 M | Nasdaq Global Market | ||
|
Beam Therapeutics
BEAM
|
$ 23.47 | 4.57 % | $ 2.32 B | Nasdaq Global Select Market | ||
|
China Biologic Products Holdings, Inc.
CBPO
|
- | 1.68 % | $ 4.65 B | Nasdaq Global Select Market | ||
|
Benitec Biopharma
BNTC
|
$ 8.11 | 2.05 % | $ 378 M | Nasdaq Capital Market | ||
|
BioNTech SE
BNTX
|
$ 87.71 | 1.74 % | $ 21.2 B | Nasdaq Global Select Market | ||
|
ANI Pharmaceuticals
ANIP
|
$ 72.29 | 0.01 % | $ 1.45 B | Nasdaq Global Market,SPB | ||
|
C4 Therapeutics
CCCC
|
$ 2.77 | 0.36 % | $ 230 M | Nasdaq Global Select Market | ||
|
Cerus Corporation
CERS
|
$ 2.18 | 0.66 % | $ 415 M | Nasdaq Global Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.